Tech Company Financing Transactions

Risalto Health Funding Round

Risalto Health closed a $7 million funding round on 11/14/2019. Investors included Health Catalyst Capital Management and Oxeon Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
The company intends to use the funds to scale its program nationwide and drive platform enhancements.

Company Information

Company Status
Private & Independent
Healthcare IT
Mailing Address
600 5th Ave. 2nd Floor
New York, NY 10020
Email Address
Launched with the backing of Oxeon Partners in 2016, Risalto aimed to bring the most effective care to every patient. In order to accomplish this, it was clear that we couldn't just create another digital health solution, we had to rethink everything from how a member becomes a patient, to that patient's relationship with their provider universe.
Risalto Health LinkedIn Company Profile
Social Media
Risalto Health Company Twitter Account
Company News
Risalto Health News
Risalto Health on Facebook
Risalto Health on YouTube

Management Team

Email & Social
Chief Executive Officer
Daniel Pizzarello
  Daniel Pizzarello LinkedIn Profile  Daniel Pizzarello Twitter Account  Daniel Pizzarello News  Daniel Pizzarello on Facebook
Chief Medical Officer
David Jevsevar
  David Jevsevar LinkedIn Profile  David Jevsevar Twitter Account  David Jevsevar News  David Jevsevar on Facebook
Randy Hutchinson
  Randy Hutchinson LinkedIn Profile  Randy Hutchinson Twitter Account  Randy Hutchinson News  Randy Hutchinson on Facebook
VP - Bus. Development
Nancy Powers
  Nancy Powers LinkedIn Profile  Nancy Powers Twitter Account  Nancy Powers News  Nancy Powers on Facebook
VP - Engineering
Sam Brochot
  Sam Brochot LinkedIn Profile  Sam Brochot Twitter Account  Sam Brochot News  Sam Brochot on Facebook
VP - Product Management
Allison Schoeneck
  Allison Schoeneck LinkedIn Profile  Allison Schoeneck Twitter Account  Allison Schoeneck News  Allison Schoeneck on Facebook



Browse more venture capital transactions:

Prev: 11/14/2019: Avidity Biosciences venture capital transaction
Next: 11/14/2019: Cutover venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The information is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary